Financials

  • Market Capitalization 5.57 B
  • Employee 103
  • Founded 2018
  • CEO N/A
  • Website www.erasca.com
  • Headquarter Delaware, United States
  • FIGI BBG00MTSR883
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-17.4
Rapporto prezzo/fatturato
1 601.5

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1198
LGND
Ligand Pharmaceuticals Incorporated - Common Stock
309.25 USD-2.21%-2.80%+21.27%+65.27%6.20 B USD
1246
BLTE
Belite Bio Inc - American Depositary Shares
147.03 USD-1.54%-5.14%+4.41%+128.59%5.78 B USD
1282
DNTH
Dianthus Therapeutics, Inc. - Common Stock
98.64 USD+1.07%+5.68%+18.29%+388.56%5.39 B USD
1301
TVTX
Travere Therapeutics, Inc. - Common Stock
56.29 USD-0.53%-2.58%+6.63%+95.66%5.23 B USD

Notizie